Bromelain-gut-health-meta-analysis: What the Evidence Says

Quick Answer

Bromelain-gut-health-meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Among these, bromelain, a cysteine protease complex derived from(pineapple), has been associated with a broad spectrum of therapeutic benefits. [Wangikar Pralhad B. (2026); evidence level 2]
• This enzymatic clearance promotes improved local blood flow contributing to pain relief and resolution of inflammation. [Wangikar Pralhad B. (2026); evidence level 2]
• Notably, the health implications of periodontitis extend beyond the oral cavity, as it has been associated with numerous systemic conditions. [Xiang Meiying (2026); evidence level 3]
• In addition to established links with cardiovascular disease, renal disease, and mental health disorders, a growing body of evidence from both animal and human studies suggests a potential association between periodontitis and non-alcoholic fatty liver disease (NAFLD). [Xiang Meiying (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For bromelain-gut-health-meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Wangikar Pralhad B. (2026). Efficacy and safety of supplementation of Exclzyme Pet for the management of arthritis and inflammatory symptoms in dogs: a randomized, double-blind, placebo-controlled pilot trial. DOI: 10.3389/fvets.2026.1803915. PMCID: PMC13261630. PMID: 42290785. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13261630/
• Xiang Meiying (2026). The correlation between periodontitis and fatty liver and the improvement of NAFLD by periodontal treatment. DOI: 10.3389/froh.2026.1706821. PMCID: PMC13283958. PMID: 42339503. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13283958/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.